Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-23-032693
Filing Date
2023-02-10
Accepted
2023-02-10 16:31:51
Documents
2
Group Members
STEFAN VITOROVICVIDA VENTURES III, L.P.VIDA VENTURES III-A, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D d631060dsc13d.htm SC 13D 95015
2 EX-99.1 d631060dex991.htm EX-99.1 5922
  Complete submission text file 0001193125-23-032693.txt   102567
Mailing Address 100 FORGE ROAD SUITE 700 WATERTOWN MA 02472
Business Address 100 FORGE ROAD SUITE 700 WATERTOWN MA 02472 857-254-4445
Vigil Neuroscience, Inc. (Subject) CIK: 0001827087 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-93233 | Film No.: 23612593
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 455 MARKET STREET, SUITE 1420 SAN FRANCISCO CA 94105
Business Address 455 MARKET STREET, SUITE 1420 SAN FRANCISCO CA 94105 (424) 313-1550
Vida Ventures GP III, L.L.C. (Filed by) CIK: 0001855502 (see all company filings)

EIN.: 861852530 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D